Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (105)

1

Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients

enthalten in: Journal of medical virology | 2021

von Kalantari, S. | Fard, S. | Maleki, D. | +4

2

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +56

CommentIn: Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. - PMID 34508887

3

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State : study protocol for a randomized controlled trial

enthalten in: Trials | 2021

von Abayomi, A. | Osibogun, A. | Ezechi, O. | +8

4

Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020

enthalten in: Terapevticheskii arkhiv | 2021

von Pshenichnaya, N. | Kareva, E. | Leneva, I. | +15

5

Umifenovir in hospitalized moderate to severe COVID-19 patients : A randomized clinical trial

enthalten in: International immunopharmacology | 2021

von Alavi Darazam, I. | Shokouhi, S. | Mardani, M. | +19

6

Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude

enthalten in: The EPMA journal | 2021

von Wang, L. | Cui, J. | OuYang, Q. | +9

7

Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients

enthalten in: Journal of medical virology | 2021

von Manganotti, P. | Bellavita, G. | Tommasini, V. | +8

8

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19 : REMAP-CAP randomized controlled trial

enthalten in: Intensive care medicine | 2021

von Arabi, Y. | Gordon, A. | Derde, L. | +165

9

COVID-19 : molecular pathophysiology, genetic evolution and prospective therapeutics-a review

enthalten in: Archives of microbiology | 2021

von Raj, C. | Kandaswamy, D. | Danduga, R. | +2

10

Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude

enthalten in: EPMA Journal | 2021

von Wang, L. | Cui, J. | OuYang, Q. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]